24.08.2013 Views

2009 Vienna - European Society of Human Genetics

2009 Vienna - European Society of Human Genetics

2009 Vienna - European Society of Human Genetics

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Molecular basis <strong>of</strong> Mendelian disorders<br />

known. While hemizygosity <strong>of</strong> the elastin gene has been associated<br />

with supravalvular aortic stenosis, studies <strong>of</strong> patients with atypical deletions<br />

and mouse models have suggested that LIMK1, CYLN2 and<br />

GTF2IRD1 might play a role in some aspects <strong>of</strong> the phenotype.<br />

To identify pathways and processes perturbed in WBS, we used<br />

microarrays to pr<strong>of</strong>ile the transcriptomes <strong>of</strong> skin fibroblast cell lines<br />

from eight young WBS and nine age-matched control girls. Using an<br />

iterative signature algorithm on our dataset combined with other skin<br />

fibroblast transcriptomes publicly available, we identified modules <strong>of</strong><br />

coherently regulated transcripts. Among our findings, two GABA-receptor<br />

genes (GABBR1 and GABRE), one glutamate receptor subunit<br />

(GRIA3) as well as a few other genes possibly related to neurological<br />

processes (SLIT3, GOLSYN and NAV1) were downregulated in WBS<br />

patients. Other modules were significantly enriched in cell adhesion<br />

and proliferation factors.<br />

These dysregulations, combined with that <strong>of</strong> at least 10 extracellular<br />

matrix proteins, constitute a potential cause for cognitive deficits and<br />

other neurological features, as they may influence CNS development<br />

by affecting cell and axonal migration. They could also modulate the<br />

function <strong>of</strong> neuronal connections by accelerating or impairing neurotransmitter<br />

release and recycling at the synaptic level.<br />

P11.125<br />

A comprehensive characterisation <strong>of</strong> human cD46, cD55 and<br />

CD59 transgenic swine fibroblasts - a potential source <strong>of</strong> nuclei<br />

for somatic cloning.<br />

J. E. Zeyland 1 , R. Slomski 1,2 , A. Wozniak 2 , A. Nowak 1 , D. Lipinski 1,2 ;<br />

1 Department <strong>of</strong> Biochemistry and Biotechnology, University <strong>of</strong> Life Sciences,<br />

Poznan, Poland, 2 Institute <strong>of</strong> <strong>Human</strong> <strong>Genetics</strong>, Polish Academy <strong>of</strong> Sciences,<br />

Poznan, Poland.<br />

Transgenic swines, especially those expressing, not a single one, but<br />

a combination <strong>of</strong> the complement system regulators are essential to<br />

help overcoming a hyperacute rejection (HAR) and necessary to estimate<br />

a potential ratio <strong>of</strong> a strategy collapse.<br />

Single and triple transgenic swine foetal fibroblasts for human coding<br />

sequences <strong>of</strong> CD46, CD55 and CD59 using a promoter <strong>of</strong> a human<br />

elongation factor 1 alpha gene were generated by lip<strong>of</strong>ection method<br />

with 80% capacity. After blasticidine selection stable lines were molecularly<br />

characterised and checked for transgene integration by PCR.<br />

Forward primers were located in the EF-1α promoter region and reverse<br />

primers in the region coding CD46, CD55 or CD59 respectively.<br />

Lines with confirmed transgene integration were subjected for characterisation<br />

<strong>of</strong> expression by RT-PCR. The transgene expression and<br />

its impact on human complement system was assessed by human<br />

complement-mediated cytolysis assay. <strong>Human</strong> serum (HS) contains<br />

complement system components which are the main reason <strong>of</strong> HAR.<br />

Each transgene expressed in single transgenic line had a protective<br />

effect on the tested cells in HS cytotoxicity assay. Also in triple transgenic<br />

lines the expression <strong>of</strong> the transgenes had a wide positive impact<br />

on the protection <strong>of</strong> cells from human complement-mediated lysis,<br />

however it was not additive. Cytogenetic analysis was performed to<br />

evaluate the chromosomal stability in the transgenic cells. Several cytogenetic<br />

staining procedures revealed, inter alia, anomalous number<br />

<strong>of</strong> the chromosomes, structural aberration and dicentromeric chromosomes.<br />

Only fully characterised cell lines can be used as nuclei donors<br />

for a somatic cloning and producing healthy transgenic animals.<br />

P11.126<br />

sOLiDtm Sequencing <strong>of</strong> Whole Genome Bisulfite Converted<br />

Libraries Prepared from Nanogram Quantities<br />

C. Lee1 , T. Halama2 , S. Ranade2 , V. Boyd2 , B. Coleman1 , K. Pearlstein1 , K.<br />

Pearlstein1 , Y. Sun2 , Z. Zhang2 , H. Peckham1 , G. Costa1 , M. Rhodes2 , K. McKernan1<br />

, F. Raffaldi3 ;<br />

1 2 Applied Biosystems, Beverly, MA, United States, Applied Biosystems, Foster<br />

City, CA, United States, 3Applied Biosystems, Italy.<br />

DNA methylation is the most characterized epigenetic mechanism,<br />

playing an essential role in normal mammalian development and is<br />

associated with gene expression and<br />

carcinogenesis. In animals, DNA methylation normally involves the<br />

modification <strong>of</strong> cytosine residues at the 5-carbon position. One popular<br />

method to study DNA methylation is to treat the sample with bisulfite.<br />

Bisulfite converts cytosine to uracil residues, but methylated cytosines<br />

are not affected. Hence, the DNA is subjected to a very specific modifi-<br />

cation dependent on methylation and sequencing <strong>of</strong> bisulfite converted<br />

DNA can yield detailed information about modified segments within a<br />

genome. Here we present a novel bisulfite conversion technique that<br />

requires only nanogram quantities <strong>of</strong> genomic DNA. The methodology<br />

was applied to two different genomes: Dh10b and Yoruba. Fragment<br />

libraries were constructed with methyl C protected adaptors and libraries<br />

were sized on Polyacrylamide gel. The DNA was bisulfite converted<br />

while still embedded in the gel piece and the library was amplified<br />

using an in-gel PCR method. These libraries were then sequenced on<br />

the SOLiD TM System, generating 50 bp reads. The high throughput <strong>of</strong><br />

the SOLiD TM System and the unique advantages <strong>of</strong> two base encoding<br />

allow the researcher to study the methylation <strong>of</strong> an entire complex genome<br />

in unprecedented detail. The results from SOLiD TM sequencing<br />

<strong>of</strong> the converted genomes and the analysis will also be discussed.<br />

P12. molecular basis <strong>of</strong> mendelian disorders<br />

P12.001<br />

the novel iVsii-i (G>A) splice donor site mutation on the alpha 1<br />

globin gene<br />

M. Taghavi*, F. Bayat, A. Amirian, A. Valaei, N. Saeidi, Z. Kaini Moghaddam, A.<br />

Kordafshari, S. Fathiazar, M. Mossayebzadeh, M. Karimipour, S. Zeinali**;<br />

Pasteur Inistitute <strong>of</strong> Iran, Tehran, Islamic Republic <strong>of</strong> Iran.<br />

More than 30 different point mutations and small deletions and insertions<br />

have been reported in alpha globin gene. Point mutations are<br />

less common, but they may occur at high frequencies in certain areas<br />

under selective pressure by malaria. Here we report the combination<br />

<strong>of</strong> IVSII-I (G>A) mutation at α1 -globin gene an β:HbD(CD121).<br />

After obtaining informed consent, blood samples (10mL) were collected<br />

in tubes containing EDTA and extracted by salting out method.<br />

Multiplex Gap PCR and direct α-globin gene sequencing techniques<br />

were used to analyze alpha globin gene mutations. Exon 3 <strong>of</strong> β-globin<br />

gene was amplified for determination <strong>of</strong> HbD variant and digested by<br />

EcoRI.<br />

Here we report a novel mutations causing α-thalassemia that has<br />

not been reported previously. The IVSII-I(G>A) mutation in α1-globin<br />

gene detected in the family with thalassemia phenotype.This mutation<br />

disrupts donor splice site <strong>of</strong> second intron <strong>of</strong> α1-globin gene.<br />

Direct sequencing revealed that the proband (7 years old child) was<br />

homozygous and the parents were heterozygous carrier. The other<br />

nucleotide change for this proband and her mother, was β:CD121<br />

GAA>GCC (known as HbD Punjab). This mutation has not been reported<br />

in globin gene server. Because it disrupts the splice site <strong>of</strong><br />

second exon, so it could be a pathologic mutation. It seems that the<br />

homozygous form <strong>of</strong> this mutation does not make HbH disease (in our<br />

case Heinz bodies were negative) and heterozygous from make a mild<br />

α-thalassemia trait.<br />

P12.002<br />

Molecular analysis <strong>of</strong> γ-globin promoters, HS-111 and 3`HS1 in<br />

beta thalassemia intermedia patients associated with high levels<br />

<strong>of</strong> HbF<br />

M. Hamid 1,2 , F. Mahjoubi 3 , A. Arab 2 , S. Zeinali 2 , M. Akbari 4 , M. Karimipoor 2 ;<br />

1 Clinical <strong>Genetics</strong> Department, National Institute <strong>of</strong> Genetic Engineering and<br />

Biotechnology (NIGEB), Tehran, Iran., Tehran, Islamic Republic <strong>of</strong> Iran, 2 Department<br />

<strong>of</strong> Molecular Medicine, Biotechnology Research Center,Pasteur Institute<br />

<strong>of</strong> Iran, Tehran, Islamic Republic <strong>of</strong> Iran, 3 Clinical <strong>Genetics</strong> Department,<br />

National Institute <strong>of</strong> Genetic Engineering and Biotechnology, Tehran, Islamic<br />

Republic <strong>of</strong> Iran, 4 Department <strong>of</strong> Medical <strong>Genetics</strong>, School <strong>of</strong> Medical Sciences,<br />

Tarbiat Modaras University,, Tehran, Islamic Republic <strong>of</strong> Iran.<br />

We have studied the nucleotide variations in promoter region <strong>of</strong><br />

gamma globin genes, HS-111 and 3`HS1 regions in β-thalassaemia<br />

intermedia, thalassemia major patients and normal individuals from<br />

Iranian origin. The five nucleotide variations in the 5’ sequences <strong>of</strong> the<br />

Aγ globin gene including -369 (C > G), -611 deletion T, -603 GA>AG<br />

in all samples, -588(A>G) in heterozygous and homozygous form and<br />

-AAGC at - 222 to -225 were found with different frequencies. In our<br />

study the -369(C>G), -611(-T),<br />

-603/604(GA>AG) mutations might as common polymorphism in our<br />

population, didn’t show any effect on expression <strong>of</strong> HbF and not correlated<br />

with β-globin mutations, Whereas most <strong>of</strong> the -588 (A) variation is<br />

related to β-thalassemia intermedia pateints especially in IVSII-I/IVSII-<br />

0

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!